Lung Cancer Surgery Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2020-2027

Lung cancer is the lethal lung tumour portrayed by the uncontrolled growth of cells in the lung tissues. The interpretation of lung cancer is confirmed by biopsy, which is carried out using bronchoscopy or CT guidance. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumour and its position within the lung
Cancer is the second-leading cause of death worldwide, accounting for 10 million deaths in 2020. As per WHO, about 1 in 6 deaths occur due to cancer. 19.3 million new cases were reported in 2020, globally. The increase in cancer incidence at a global scale also indicates an increasing trend for the prevalence of lung cancers worldwide. In this scenario characterized by a favourable funding environment and effective treatment options, the growing incidence and prevalence of cancer are expected to increase the number of patients opting for lung cancer surgery in the coming years. This, in turn, is expected to drive the growth of the market in the coming years

GET FREE SAMPLE PDF:https://www.wiseguyreports.com/sample-request/7258488-lung-cancer-surgery-market-current-analysis-and-forecast-2021-2027

Lung cancer treatments are primarily divided into four broader categories; diagnosis/imaging, surgeries, pharmacological assistance, and indirect costs (like transportation, caregiver wages, lodging, secondary effects treatments, and lost wages/ incomes). These categories incur substantial spending from government/insurance providers and additional costs paid by the patient itself. The hefty costs for treating lung cancers have created a substantial burden on the governments globally and cancer patients. Considering these high costs, despite the presence of a large patient pool, a limited number of patients opt for surgical interventions to treat their condition. This is a major factor restraining market growth

REPORT DETAILS:https://www.wiseguyreports.com/reports/7258488-lung-cancer-surgery-market-current-analysis-and-forecast-2021-2027

Based on surgery types, the market is fragmented into thoracotomy and Minimally Invasive Surgeries. However, the minimally invasive surgeries segment is expected to grow at the highest during the forecast period owing to the growing adoption of minimally invasive techniques, and the increasing trend of robotic surgeries. Thoracotomy is further bifurcated to lobectomy, sleeve resection, segmentectomy, and pneumonectomy surgeries.
Based on the device type, the market is fragmented into surgical, monitoring, and endo-surgical devices. The rising prevalence & incidence of lung cancer are the factors driving the market growth

ALSO READ:http://www.marketwatch.com/story/shop-floor-control-software-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-06-24

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. owing to the improved healthcare infrastructure and increase in healthcare spending
Some of the major players operating in the market include GE Healthcare, Johnson and Johnson, Olympus Corporation, Siemens Healthineers AG, Ethicon Inc., Medtronic Plc., KARL STORZ GmbH, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions

ALSO READ:http://www.marketwatch.com/story/liquid-argon-market-size-share-value-and-competitive-landscape-2021-2026-2021-06-25

TABLE OF CONTENTS

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Lung Cancer Surgery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Lung Cancer Surgery Market
2.1.1 Main Objective of the Global Lung Cancer Surgery Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPs UNDER LUNG CANCER SURGERY INDUSTRY
6 COVID-19 IMPACT
7 GLOBAL LUNG CANCER SURGERY MARKET REVENUE
8 MARKET INSIGHTS BY SURGERY
8.1 Thoracotomy
8.1.1 Lobectomy
8.1.2 Sleeve Resection
8.1.3 Segmentectomy
8.1.4 Pneumonectomy
8.2 Minimally Invasive Surgery
9 MARKET INSIGHTS BY DEVICE
9.1 Surgical Devices
9.2 Monitoring Devices
9.3 Endo-surgical Devices

ALSO READ:http://www.marketwatch.com/story/overheat-detection-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-06-28

10 MARKET INSIGHTS BY REGION
10.1 NORTH AMERICA LUNG CANCER SURGERY MARKET
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 EUROPE LUNG CANCER SURGERY MARKET
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Spain
10.2.5 Italy
10.2.6 Rest of Europe
10.3 ASIA PACIFIC LUNG CANCER SURGERY MARKET
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 Rest of Asia Pacific
10.4 REST OF THE WORLD LUNG CANCER SURGERY MARKET
11 LUNG CANCER SURGERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 LUNG CANCER SURGERY MARKET OPPORTUNITIES
16 LUNG CANCER SURGERY MARKET TRENDS & INSIGHTS
17 COMPETITIVE SCENARIO
17.1 Porter’s Five forces analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
18 COMPANY PROFILED
18.1 Medtronic PLC
18.2 Accuracy Incorporated
18.3 GE Healthcare
18.4 Johnson and Johnson
18.5 Olympus Corporation
18.6 Siemens Healthineers AG
18.7 Ethicon Inc.
18.8 KARL STORZ GmbH
19 DISCLAIMER —-

….. continued

 CONTACT DETAILS:        

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105

Source – HeraldKeeper
Note: The Heraldkeeper News Department was not involved in the creation of this content.

If you have any problem with this press release? Contact the source provider Heraldkeeper.com, you can contact them here.

Related Articles

Stay Connected

0FansLike
2,985FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles